Literature DB >> 28057254

HIV and Nonischemic Heart Disease.

Pravin Manga1, Keir McCutcheon2, Nqoba Tsabedze2, Ahmed Vachiat2, Don Zachariah2.   

Abstract

Human immunodeficiency virus (HIV)-associated heart disease encompasses a broad spectrum of diseases. HIV infection may involve the pericardium, myocardium, coronary arteries, pulmonary vasculature, and valves, as well as the systemic vasculature. Access to combination antiretroviral therapy, as well as health resources, has had a significant influence on the prevalence and severity of the effects on each cardiac structure. Investigations over the recent past have improved our understanding of the epidemiology and pathophysiology of HIV-associated cardiovascular disease. This review will focus on our current understanding of pathogenesis and risk factors associated with HIV infection and heart disease, and it will discuss relevant advances in diagnosis and management of these conditions.
Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HIV-associated cardiomyopathy; HIV-associated pulmonary artery hypertension; acquired immunodeficiency syndrome; antiretroviral agents

Mesh:

Year:  2017        PMID: 28057254     DOI: 10.1016/j.jacc.2016.09.977

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  12 in total

Review 1.  Drug abuse and HIV-related pulmonary hypertension: double hit injury.

Authors:  Zachery J Harter; Stuti Agarwal; Pranjali Dalvi; Norbert F Voelkel; Navneet K Dhillon
Journal:  AIDS       Date:  2018-11-28       Impact factor: 4.177

2.  Clinical characteristics of HIV-infected patients with adjudicated heart failure.

Authors:  Alexandra B Steverson; Anna E Pawlowski; Daniel Schneider; Prasanth Nannapaneni; Jes M Sanders; Chad J Achenbach; Sanjiv J Shah; Donald M Lloyd-Jones; Matthew J Feinstein
Journal:  Eur J Prev Cardiol       Date:  2017-09-25       Impact factor: 7.804

3.  Cardiac and inflammatory biomarkers in perinatally HIV-infected and HIV-exposed uninfected children.

Authors:  James D Wilkinson; Paige L Williams; Wendy Yu; Steven D Colan; Armando Mendez; Justin P V Zachariah; Russell B Van Dyke; William T Shearer; Renee E Margossian; Steven E Lipshultz
Journal:  AIDS       Date:  2018-06-19       Impact factor: 4.177

4.  The hidden continuum of HIV-associated cardiomyopathy: A focussed review with case reports.

Authors:  Pieter-Paul S Robbertse; Anton F Doubell; Jean B Nachega; Philip G Herbst
Journal:  SA Heart J       Date:  2021-10-27

5.  Mitochondrial dysfunction in human immunodeficiency virus-1 transgenic mouse cardiac myocytes.

Authors:  Joseph Y Cheung; Jennifer Gordon; JuFang Wang; Jianliang Song; Xue-Qian Zhang; Fabian Jana Prado; Santhanam Shanmughapriya; Sudarsan Rajan; Dhanendra Tomar; Farzaneh G Tahrir; Manish K Gupta; Tijana Knezevic; Nana Merabova; Christopher D Kontos; Joseph M McClung; Paul E Klotman; Muniswamy Madesh; Kamel Khalili; Arthur M Feldman
Journal:  J Cell Physiol       Date:  2018-09-07       Impact factor: 6.384

6.  Predictors of electrocardiographic QT interval prolongation in men with HIV.

Authors:  Katherine C Wu; Long Zhang; Sabina A Haberlen; Hiroshi Ashikaga; Todd T Brown; Matthew J Budoff; Gypsyamber D'Souza; Lawrence A Kingsley; Frank J Palella; Joseph B Margolick; Otoniel Martínez-Maza; Elsayed Z Soliman; Wendy S Post
Journal:  Heart       Date:  2018-10-26       Impact factor: 5.994

7.  Dysregulation of mitochondrial bioenergetics and quality control by HIV-1 Tat in cardiomyocytes.

Authors:  Farzaneh G Tahrir; Santhanam Shanmughapriya; Taha Mohseni Ahooyi; Tijana Knezevic; Manish K Gupta; Christopher D Kontos; Joseph M McClung; Muniswamy Madesh; Jennifer Gordon; Arthur M Feldman; Joseph Y Cheung; Kamel Khalili
Journal:  J Cell Physiol       Date:  2017-07-31       Impact factor: 6.513

8.  Electrocardiographic and echocardiographic abnormalities in urban African people living with HIV in South Africa.

Authors:  Geert V T Roozen; Ruchika Meel; Joyce Peper; William D F Venter; Roos E Barth; Diederick E Grobbee; Kerstin Klipstein-Grobusch; Alinda G Vos
Journal:  PLoS One       Date:  2021-02-02       Impact factor: 3.240

9.  Circulating β-d-Glucan as a Marker of Subclinical Coronary Plaque in Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus.

Authors:  Stéphane Isnard; Brandon Fombuena; Manel Sadouni; John Lin; Corentin Richard; Bertrand Routy; Jing Ouyang; Rayoun Ramendra; Xiaorong Peng; Yonglong Zhang; Malcolm Finkelman; Daniel Tremblay-Sher; Cecile Tremblay; Carl Chartrand-Lefebvre; Madeleine Durand; Jean-Pierre Routy
Journal:  Open Forum Infect Dis       Date:  2021-03-07       Impact factor: 4.423

10.  The Use of First Line Highly Active Anti-Retroviral Therapy (HAART) is Not Associated with Qtc Prolongation in HIV Patients.

Authors:  James Ogunmodede; Philip Kolo; Ibraheem Katibi; Ayodele Omotoso
Journal:  Ethiop J Health Sci       Date:  2017-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.